Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$424M |
| 2 |
Bath & Body Works
BBWI
|
+$342M |
| 3 |
Home Depot
HD
|
+$259M |
| 4 |
GE Aerospace
GE
|
+$247M |
| 5 |
Palo Alto Networks
PANW
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LNKD
LinkedIn Corporation
LNKD
|
+$917M |
| 2 |
ARMH
ARM HOLDINGS PLC ADS
ARMH
|
+$396M |
| 3 |
Citigroup
C
|
+$377M |
| 4 |
Sherwin-Williams
SHW
|
+$292M |
| 5 |
Starbucks
SBUX
|
+$260M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 20.46% |
| 2 | Healthcare | 16.66% |
| 3 | Communication Services | 14.21% |
| 4 | Technology | 13.93% |
| 5 | Financials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Alnylam Pharmaceuticals
ALNY
$38.3B
| $60.9M | 0.06% |
970,453
-519,088
| -35% | -$34.5M |
|
252
Macy's
M
$6.51B
| $60.5M | 0.06% |
+1,371,063
| New | +$56.7M |
|
|
BRCD
253
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $60.2M | 0.06% |
5,687,181
-19,202
| -0.3% | -$175K |
|
|
DBD
254
DELISTED
Diebold Nixdorf Incorporated
DBD
| $59M | 0.06% |
2,040,172
-74,529
| -4% | -$1.95M |
|
|
ZOES
255
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $58.1M | 0.06% |
1,490,681
-29,888
| -2% | -$941K |
|
256
Broadcom
AVGO
$1.76T
| $57.9M | 0.06% |
+3,744,660
| New | +$50.6M |
|
257
Trip.com Group
TCOM
$29B
| $57.1M | 0.06% |
1,291,075
+463,022
| +56% | +$19.4M |
|
|
XEC
258
DELISTED
CIMAREX ENERGY CO
XEC
| $56.8M | 0.06% |
583,559
-129,510
| -18% | -$11.4M |
|
259
Korn Ferry
KFY
$4.31B
| $56.3M | 0.06% |
1,989,527
+39,521
| +2% | +$1.13M |
|
|
CSRA
260
DELISTED
CSRA Inc.
CSRA
| $55.3M | 0.06% |
2,055,615
-336,133
| -14% | -$8.79M |
|
|
PXD
261
DELISTED
Pioneer Natural Resource Co.
PXD
| $54.9M | 0.06% |
390,013
-27,052
| -6% | -$3.35M |
|
262
The GEO Group
GEO
$4B
| $54.7M | 0.06% |
2,367,755
-728,256
| -24% | -$14.2M |
|
263
Live Nation Entertainment
LYV
$42.9B
| $53.6M | 0.06% |
2,401,304
+32,595
| +1% | +$712K |
|
|
OTIC
264
DELISTED
Otonomy, Inc.
OTIC
| $53.3M | 0.06% |
3,569,745
+888,654
| +33% | +$14M |
|
265
Lear
LEA
$7.39B
| $53.1M | 0.06% |
477,988
-507,422
| -51% | -$53.7M |
|
|
XENT
266
DELISTED
Intersect ENT, Inc
XENT
| $53.1M | 0.06% |
2,794,806
+23,901
| +0.9% | +$433K |
|
267
Molina Healthcare
MOH
$10.4B
| $53.1M | 0.06% |
822,852
-853,163
| -51% | -$50.7M |
|
|
CSOD
268
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $52.2M | 0.05% |
1,593,617
-19,312
| -1% | -$583K |
|
|
FCE.A
269
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $51.9M | 0.05% |
2,459,180
+5,987
| +0.2% | +$118K |
|
270
Pebblebrook Hotel Trust
PEB
$2.18B
| $51.8M | 0.05% |
1,780,293
+194,424
| +12% | +$5.04M |
|
271
PUT
State Street SPDR S&P Biotech ETF
XBI
$10B
| $51.7M | 0.05% |
1,000,000
-1,000,000
| -50% | -$51.9M |
|
|
ETP
272
DELISTED
Energy Transfer Partners L.p.
ETP
| $51.6M | 0.05% |
1,595,536
+887,811
| +125% | +$24.7M |
|
273
JB Hunt Transport Services
JBHT
$25.9B
| $51.2M | 0.05% |
+608,007
| New | +$46.1M |
|
274
TripAdvisor
TRIP
$1.7B
| $51.2M | 0.05% |
769,937
-8,894
| -1% | -$589K |
|
275
Pacira BioSciences
PCRX
$1.04B
| $50.5M | 0.05% |
954,110
+12,123
| +1% | +$709K |
|
Similar funds
Jennison Associates's Q1 2016 Portfolio in Review
As of Q1 2016, Jennison Associates held 710 positions worth $95.3B, down 6.5% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jennison Associates's Q1 2016 filing shows 56 new, 303 increased, 241 reduced and 102 closed positions. Its largest new stake was Procter & Gamble: 1,657,581 shares worth $136M. The largest sale was LinkedIn Corporation, an estimated $917M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Communication Services.
- Jennison Associates's largest Q1 2016 buy was Procter & Gamble: 1,657,581 shares worth $136M.
- Jennison Associates added most to Microsoft in Q1 2016, an estimated $424M increase.
- Jennison Associates's biggest Q1 2016 reduction was LinkedIn Corporation, cutting an estimated $917M.
- Jennison Associates fully exited Sherwin-Williams in Q1 2016, selling an estimated $292M.
- Jennison Associates's ten largest holdings make up 24% of its $95.3B portfolio in Q1 2016.
- Jennison Associates opened 56 new positions and closed 102 in Q1 2016.
- Jennison Associates's portfolio value fell 6.5% quarter-over-quarter to $95.3B.
Based on Jennison Associates's 13F filing for Q1 2016, filed 3 May 2016.